European neuropsychopharmacology : the journal of the European College of NeuropsychopharmacologyLetter

15 Feb 2025

Letter to the editor concerning: "Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis".

No abstract available

COI Statement

Declaration of competing interests The author declares no competing interests.

Article info

Journal issue:

  • Volume: 94
  • Issue: not provided

Doi:

10.1016/j.euroneuro.2025.01.010

More resources:

Elsevier Science

Full Text Sources

Paid

Share: